Seoul, South Korea

Shin Jeong Lee

USPTO Granted Patents = 1 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Shin Jeong Lee in Vascular Endothelial Cell Culture

Introduction

Shin Jeong Lee is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of cell culture, particularly in the isolation and maintenance of vascular endothelial cells. His work is crucial for advancements in medical research and therapeutic applications.

Latest Patents

Shin Jeong Lee holds a patent titled "Method of isolation of culture of vascular endothelial cells, medium for maintaining characteristics of vascular endothelial cells, and culture method including same." This patent describes a method for isolating a pure culture of vascular endothelial cells. The method allows for the isolation of homogeneous endothelial cells adhered to a matrix for a specific time, derived from human pluripotent stem cells. The patent also details a medium that maintains the characteristics of these cells, comprising high-purity vascular endothelial cells, FGF2, EGF, VEGF-A, ascorbic acid, and DMEM/F-12 as active ingredients.

Career Highlights

Shin Jeong Lee is currently associated with Karis Bio Inc., where he continues to innovate in the field of cell biology. His work has the potential to impact various medical applications, including regenerative medicine and tissue engineering.

Collaborations

Shin Jeong Lee collaborates with Young Sup Yoon, contributing to advancements in their shared field of research.

Conclusion

Shin Jeong Lee's innovative work in the isolation and culture of vascular endothelial cells represents a significant advancement in biomedical research. His contributions are essential for future developments in medical therapies and applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…